Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
atomoxetine hydrochloride, Quantity: 45.72 mg (Equivalent: atomoxetine, Qty 40 mg)
Arrotex Pharmaceuticals Pty Ltd
Atomoxetine hydrochloride
Capsule, hard
Excipient Ingredients: colloidal anhydrous silica; Gelatin; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; indigo carmine; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; Shellac; sulfuric acid
Oral
28 capsules, 14 capsules, 7 capsules, 56 capsules
(S4) Prescription Only Medicine
ATOMOXETINE GPPL is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as defined by DSM-IV criteria in children 6 years of age and older, adolescents and adults.
Visual Identification: Blue capsules with the printed markings 40 mg on the capsule body; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2016-01-22